Novo Nordisk sales by therapy area 2021-2022

Danish drug manufacturer Novo Nordisk generated some 156 billion kroner – or some 88 percent of its total sales – in the diabetes and obesity care segment. The biopharma/rare disease segment was significantly lower, generating some 20.5 billion kroner of the company’s total sales.

…. more: Statista.com (Quelle/Source)